- Home
- Automated
- List of product information
- NEUROBION TABLET [SIN06258P]
NEUROBION TABLET [SIN06258P]
Active ingredients: NEUROBION TABLET
Product Info
NEUROBION TABLET
[SIN06258P]
Product information
Active Ingredient and Strength | CYANOCOBALAMIN - 200 MCG |
Dosage Form | TABLET, SUGAR COATED |
Manufacturer and Country | P&G HEALTH AUSTRIA GMBH CO. OG - AUSTRIA |
Registration Number | SIN06258P |
Licence Holder | PROCTER & GAMBLE (SINGAPORE) PTE LTD |
Forensic Classification | PHARMACY ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | A11DB |
Indications
Neurobion is indicated for neurological and other disorders associated with disturbance of metabolic functions influenced by B complex vitamins, including diabetic polyneuropathy, alcoholic peripheral neuritis and post influenzal neuropathies.
Neurobion is also recommended for the treatment of neuritis and neuralgia of the spinal nerves, especially facial paresis, cervical syndrome, low back pain, ischialgia.
Dosage and administration
1 coated tablet three times daily to treat moderate cases, or to provide interval and follow-up therapy for a course of injections.
Neurobion coated tablets are swallowed without chewing with a little liquid with or after meals.
The duration of the treatment is determined by the doctor.
Contraindications
Neurobion must not be used in patients hypersensitive to any of the active ingredients or excipients of the product (see ‘Composition’ – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).
Neurobion coated tablets are not suitable for the treatment of children due to the high content of active ingredients.
